Won Chan Leea, et al. - Conclusions: Long-term healthcare costs of SAH and ICH are substantial. With the expected increase in the elderly population over the coming decades, these results emphasize the need for effective preventive and acute medical care
Your Unread Messages in Neurology
Messages include industry-supported communications and special communications from MDLinx
MDLinx Select Partners
Merck & Co., Inc.
Free Downloadable Resources to Help You Help Your Patients With Migraine
1 B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial The Lancet Neurology, August 17, 2010
2 New drugs in migraine treatment and prophylaxis: telcagepant and topiramate The Lancet, August 24, 2010
3 Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-l). Final results Stroke, August 30, 2010
4 Adalimumab in severe and acute sciatica: A multicenter, randomized, double-blind, placebo-controlled trial Arthritis & Rheumatism, August 5, 2010
5 Higher 25-hydroxyvitamin D is associated with lower relapse risk in MS Annals of Neurology , August 3, 2010
6 Pathological gambling in PD is reduced by amantadine Annals of Neurology , August 4, 2010
7 Investigation of High-Sensitivity C-reactive Protein and Erythrocyte Sedimentation Rate in Low Back Pain Patients The Korean Journal of Pain, August 11, 2010 Free full text
8 Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR The Lancet Neurology, August 18, 2010
9 Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis The Lancet Neurology, August 26, 2010
10 Persistence with stroke prevention medications 3 months after hospitalization Archives of Neurology, August 10, 2010
11 Acute and preventive pharmacologic treatment of cluster headache Neurology, August 6, 2010 Evidence Based Medicine
12 Plasma {beta}-amyloid and cognitive decline Archives of Neurology, August 31, 2010
13 Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial The Lancet Neurology, August 20, 2010
14 Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people Archives of Neurology, August 25, 2010
15 Successful treatment of melanoma brain metastases with adoptive cell therapy Clinical Cancer Research, August 27, 2010
16 Low back pain management: Approaches to treatment The Journal of Musculoskeletal Medicine, August 12, 2010 Free full text
17 Statins for the treatment of dementia Cochrane Reviews, August 18, 2010
18 The Role of Inflammation in the Pathogenesis of Delirium and Dementia in Older Adults: A Review CNS Neuroscience & Therapeutics, August 6, 2010
19 Early-onset ischaemic stroke Thrombosis and Haemostasis, August 13, 2010
20 TGF-beta-1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease CNS Neuroscience & Therapeutics, August 12, 2010
Indexed Journals in Neurology: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injury more
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
Receive free subspecialty
"5-minute updates" via email
Send the E-mail Newsletter to a Colleague
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Sponsor
